The electronic fetal monitoring (EFM) and the intermittent auscultation are the main methods of monitoring the fetal surveillance in labour.
The electronic fetal monitoring developed with the expectation to prevent fetal neurological damage or/and perinatal death.
The intrapartum and the admission use of the electronic fetal monitoring increased rapidly since its introduction.
Thus, a guideline entitled 'The Use of Electronic Fetal Monitoring' was developed in United Kingdom by NICE in 2001.
Although, in recent surveys was found that many units in UK and in other European countries didn't implement the evidence regarding fetal monitoring.
There is evidence that shows that the continuous EFM, especially in low risk labours, may increase the rate of operative deliveries without benefit the neonate.
Thus, the non implementation of the evidence can cause increase in the maternal morbidity and mortality and economical implications.
Many interventions, such as training, audit and feedback, local opinion leaders, could be used in order to achieve a successful implementation of the evidence.
(EN)
Review of Clinical Pharmacology and Pharmacokinetics
(EN)
